Nephrotic Syndrome Clinical Trials

Find Nephrotic Syndrome Clinical Trials Near You

A Study on the Influencing Factors of Glucocorticoid Induced Elevated Blood Glucose in Nephrotic Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus;

• Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone;

Locations
Other Locations
China
Zhejiang provincial people's hospital
RECRUITING
Hangzhou
Contact Information
Primary
Xiaolan Ye, master
yexl1120@126.com
+86-0571-85893117
Backup
Ping Huang, doctor
huangping1841@zjcc.org.cn
+86-0571-85893117
Time Frame
Start Date: 2024-01-10
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 300
Treatments
Blood glucose management in patients with kidney disease after using glucocorticoids
Blood glucose monitoring for kidney disease patients after taking glucocorticoids
Related Therapeutic Areas
Sponsors
Collaborators: The Third Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital, Nanxun District People's Hospital of Huzhou City,China, The First People's Hospital of Chun'an, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Wenling Traditional Chinese Medicine Hospital, Affiliated Hospital of Jiaxing University, The First People's Hospital of Xiaoshan District, Hangzhou City
Leads: Zhejiang Provincial People's Hospital

This content was sourced from clinicaltrials.gov